MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 68 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -25.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -23.1% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $13,000 | +62.5% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -27.3% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $11,000 | -21.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $14,000 | +75.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | -88.6% | 10,000 | -88.9% | 0.00% | -83.3% |
| Q2 2020 | $70,000 | +29.6% | 90,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $54,000 | -52.6% | 90,000 | +80.0% | 0.01% | -50.0% |
| Q4 2019 | $114,000 | +256.2% | 50,000 | 0.0% | 0.01% | +200.0% |
| Q3 2019 | $32,000 | -25.6% | 50,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $43,000 | -21.8% | 50,000 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $55,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
| Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
| IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
| Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
| BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
| Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |